Status:

COMPLETED

A Study on the Effectiveness of Antioxidant Supplementation in Tinnitus

Lead Sponsor:

National and Kapodistrian University of Athens

Conditions:

Tinnitus

Eligibility:

All Genders

25-75 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to assess the effectiveness of antioxidant supplementation in idiopathic tinnitus patients. To investigate this, a double-blind, randomized, and placebo-controlled clinic...

Eligibility Criteria

Inclusion

  • Age 25-75 years old
  • Unilateral or bilateral chronic idiopathic persistent tinnitus of at least 6 months' duration
  • Tinnitus Handicap Inventory score rated ≥ 4 at baseline
  • With a normal audiogram or up to medium-grade neurosensory hearing loss.
  • Tinnitus maskable (by noise masking) with noise at least 5 decibel
  • Childbearing age with a negative pregnancy test at eligibility and baseline assessment
  • Stable medication during the whole period of the 3-month intervention
  • Willing and able to attend the on-study visits
  • Able to read and understand the relevant study documents and rating scales and follow investigator instructions during audiologic measurements

Exclusion

  • Tinnitus following acute acoustic trauma, sudden deafness or traumatic head or neck injury
  • Intermittent tinnitus
  • Meniere's Disease, otosclerosis, acute or chronic otitis media
  • Head and neck radiotherapy
  • Active GI disease; active malignant diseases; autoimmune diseases; cardiovascular disease; renal or hepatic disorders; haemorrhagic diathesis
  • Intake of anticoagulants; ototoxic medications; tinnitus-inducing medication (e.g. aminoglycosides, chemotherapeutics, loop diuretics, high doses of aspirin or quinine)
  • Psychiatric disorders
  • Unregulated diabetes mellitus, hypertension or thyroid disease
  • Alcohol or drug abuse
  • Vitamin or inorganic supplements, vegan or macrobiotic diet before and during the trial
  • Pregnancy, lactation

Key Trial Info

Start Date :

January 10 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 25 2019

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT04105426

Start Date

January 10 2019

End Date

May 25 2019

Last Update

November 13 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

General Hospital of Athens "Hippocratio", Department of Otorhinolaryngology

Athens, Greece